Logo image of SKK

SKK HOLDINGS LTD (SKK) Stock Fundamental Analysis

NASDAQ:SKK - Nasdaq - KYG8292E1026 - Common Stock - Currency: USD

0.9522  -0.01 (-0.81%)

After market: 0.952 0 (-0.02%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SKK. SKK was compared to 47 industry peers in the Construction & Engineering industry. SKK has a bad profitability rating. Also its financial health evaluation is rather negative. SKK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SKK has reported negative net income.
In the past year SKK had a positive cash flow from operations.
SKK Yearly Net Income VS EBIT VS OCF VS FCFSKK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M 4M

1.2 Ratios

SKK's Return On Assets of -2.49% is on the low side compared to the rest of the industry. SKK is outperformed by 71.11% of its industry peers.
SKK's Return On Equity of -24.10% is on the low side compared to the rest of the industry. SKK is outperformed by 82.22% of its industry peers.
Industry RankSector Rank
ROA -2.49%
ROE -24.1%
ROIC N/A
ROA(3y)7.68%
ROA(5y)N/A
ROE(3y)37.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SKK Yearly ROA, ROE, ROICSKK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 20 40 60

1.3 Margins

SKK has a better Gross Margin (34.70%) than 88.89% of its industry peers.
The Profit Margin and Operating Margin are not available for SKK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SKK Yearly Profit, Operating, Gross MarginsSKK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 10 20 30 40

1

2. Health

2.1 Basic Checks

SKK does not have a ROIC to compare to the WACC, probably because it is not profitable.
SKK has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, SKK has a worse debt to assets ratio.
SKK Yearly Shares OutstandingSKK Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M
SKK Yearly Total Debt VS Total AssetsSKK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of 1.24, we must say that SKK is in the distress zone and has some risk of bankruptcy.
SKK has a worse Altman-Z score (1.24) than 80.00% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that SKK is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.10, SKK is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 1.24
ROIC/WACCN/A
WACC10.92%
SKK Yearly LT Debt VS Equity VS FCFSKK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 2M -2M 4M

2.3 Liquidity

SKK has a Current Ratio of 0.57. This is a bad value and indicates that SKK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SKK (0.57) is worse than 93.33% of its industry peers.
A Quick Ratio of 0.56 indicates that SKK may have some problems paying its short term obligations.
The Quick ratio of SKK (0.56) is worse than 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.56
SKK Yearly Current Assets VS Current LiabilitesSKK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

The earnings per share for SKK have decreased strongly by -118.06% in the last year.
Looking at the last year, SKK shows a decrease in Revenue. The Revenue has decreased by -6.70% in the last year.
EPS 1Y (TTM)-118.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.83%
Revenue 1Y (TTM)-6.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-21.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SKK Yearly Revenue VS EstimatesSKK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2M 4M 6M 8M 10M
SKK Yearly EPS VS EstimatesSKK Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SKK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SKK Price Earnings VS Forward Price EarningsSKK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SKK is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.17
SKK Per share dataSKK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SKK!.
Industry RankSector Rank
Dividend Yield N/A

SKK HOLDINGS LTD

NASDAQ:SKK (2/5/2025, 8:27:17 PM)

After market: 0.952 0 (-0.02%)

0.9522

-0.01 (-0.81%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.87M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.08
P/FCF N/A
P/OCF 20.13
P/B 10.24
P/tB 10.28
EV/EBITDA 14.17
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.05
OCFY4.97%
SpS0.88
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.49%
ROE -24.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.7%
FCFM N/A
ROA(3y)7.68%
ROA(5y)N/A
ROE(3y)37.99%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.84%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 0.11
Cap/Depr 183.47%
Cap/Sales 19.1%
Interest Coverage N/A
Cash Conversion 52.37%
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.56
Altman-Z 1.24
F-Score3
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)153.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)18.58%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-21.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-101.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-298.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.56%
OCF growth 3YN/A
OCF growth 5YN/A